I agree that this site is using cookies. You can find further informations here.
X
Passaro, Antonio
149  results:
Articles (Online) X
Search for persons X
?
1

Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-..:

Attili, Ilaria ; Fuorivia, Valeria ; Spitaleri, Gianluca...
Cancers.  16 (2024)  13 - p. 2457 , 2024
Link: https://doi.org/10.3390/..
 
?
2

The Evolving Scenario of ES-SCLC Management: From Biology t..:

Trillo Aliaga, Pamela ; Del Signore, Ester ; Fuorivia, Valeria...
Genes.  15 (2024)  6 - p. 701 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Cancer biomarkers: Emerging trends and clinical implication..:

Passaro, Antonio ; Al Bakir, Maise ; Hamilton, Emily G....
Cell.  187 (2024)  7 - p. 1617-1635 , 2024
Link: https://doi.org/10.1016/..
 
?
4

PP01.24 FURVENT: Phase 3 trial testing furmonertinib vs che..:

Spira, Alexander ; Cho, Byoung Chul ; Felip, Enriqueta...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e17-e18 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Clinical evidence and adverse event management update of pa..:

Russo, Giuseppe Lo ; Bironzo, Paolo ; Bennati, Chiara...
Critical Reviews in Oncology/Hematology.  194 (2024)  - p. 104243 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Post-Progression Analysis of EGFR-Mutant NSCLC Following Os..:

Attili, Ilaria ; Corvaja, Carla ; Spitaleri, Gianluca...
Cancers.  16 (2024)  14 - p. 2589 , 2024
Link: https://doi.org/10.3390/..
 
?
7

Surgically Treated pT2aN0M0 (Stage IB) Non-Small Cell Lung ..:

Casiraghi, Monica ; Petrella, Francesco ; Bardoni, Claudia...
Journal of Clinical Medicine.  12 (2023)  5 - p. 2081 , 2023
Link: https://doi.org/10.3390/..
 
?
8

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long an..:

Spitaleri, Gianluca ; Trillo Aliaga, Pamela ; Attili, Ilaria...
Cancers.  15 (2023)  19 - p. 4779 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Immune checkpoint inhibitors in EGFR-mutant non-small cell ..:

Attili, Ilaria ; Passaro, Antonio ; Corvaja, Carla...
Cancer Treatment Reviews.  119 (2023)  - p. 102602 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatm..:

Petrella, Francesco ; Rizzo, Stefania ; Attili, Ilaria...
Current Oncology.  30 (2023)  3 - p. 3160-3175 , 2023
Link: https://doi.org/10.3390/..
 
?
11

Sustained Improvement in the Management of Patients with No..:

Spitaleri, Gianluca ; Trillo Aliaga, Pamela ; Attili, Ilaria...
Current Oncology.  30 (2023)  5 - p. 5072-5092 , 2023
Link: https://doi.org/10.3390/..
 
?
12

New Generations of Tyrosine Kinase Inhibitors in Treating N..:

Attili, Ilaria ; Corvaja, Carla ; Spitaleri, Gianluca...
Cancers.  15 (2023)  20 - p. 5079 , 2023
Link: https://doi.org/10.3390/..
 
?
13

Pralsetinib in RET fusion-positive non-small-cell lung canc..:

Passaro, Antonio ; Russo, Giuseppe Lo ; Passiglia, Francesco...
Lung Cancer.  174 (2022)  - p. 118-124 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Can..:

Attili, Ilaria ; Passaro, Antonio ; Pisapia, Pasquale..
Current Oncology.  29 (2022)  1 - p. 255-266 , 2022
Link: https://doi.org/10.3390/..
 
?
15

Comparison of real-world data (RWD) analysis on efficacy an..:

Attili, Ilaria ; Valenza, Carmine ; Santoro, Celeste...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
1-15